Effects of Intranasal Fluticasone Plus Azelastine on Airway Inflammation in Patients With Asthma & Allergic Rhinitis (MAN06)
Proof of Concept Study to Assess Downstream Effects of Using Combined Intranasal Fluticasone Propionate Plus Azelastine Nasal Spray on Asthmatic Inflammation in Patients With Persistent Asthma and Allergic Rhinitis
Sponsor: University of Dundee
Terminated
The company providing study IMP was unable to supply further batches of IMP.
Other terminated trials from University of Dundee
Listed as NCT02953106, this PHASE4 trial focuses on Allergy and Asthma, Allergic and remains terminated or withdrawn. Sponsored by University of Dundee, it has been updated 9 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE4
-
May 2019 — Jan 2021 [monthly]
Terminated PHASE4
-
Nov 2018 — May 2019 [monthly]
Terminated PHASE4
Status: Recruiting → Terminated
▶ Show 4 earlier versions
-
Aug 2018 — Nov 2018 [monthly]
Recruiting PHASE4
-
Jun 2018 — Aug 2018 [monthly]
Recruiting PHASE4
-
Apr 2018 — Jun 2018 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Jan 2017 — Apr 2018 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of Dundee
For direct contact, visit the study record on ClinicalTrials.gov .